Literature DB >> 17318184

Puromycin-sensitive aminopeptidase is the major peptidase responsible for digesting polyglutamine sequences released by proteasomes during protein degradation.

N Bhutani1, P Venkatraman, A L Goldberg.   

Abstract

Long stretches of glutamine (Q) residues are found in many cellular proteins. Expansion of these polyglutamine (polyQ) sequences is the underlying cause of several neurodegenerative diseases (e.g. Huntington's disease). Eukaryotic proteasomes have been found to digest polyQ sequences in proteins very slowly, or not at all, and to release such potentially toxic sequences for degradation by other peptidases. To identify these key peptidases, we investigated the degradation in cell extracts of model Q-rich fluorescent substrates and peptides containing 10-30 Q's. Their degradation at neutral pH was due to a single aminopeptidase, the puromycin-sensitive aminopeptidase (PSA, cytosol alanyl aminopeptidase). No other known cytosolic aminopeptidase or endopeptidase was found to digest these polyQ peptides. Although tripeptidyl peptidase II (TPPII) exhibited limited activity, studies with specific inhibitors, pure enzymes and extracts of cells treated with siRNA for TPPII or PSA showed PSA to be the rate-limiting activity against polyQ peptides up to 30 residues long. (PSA digests such Q sequences, shorter ones and typical (non-repeating) peptides at similar rates.) Thus, PSA, which is induced in neurons expressing mutant huntingtin, appears critical in preventing the accumulation of polyQ peptides in normal cells, and its activity may influence susceptibility to polyQ diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17318184      PMCID: PMC1817637          DOI: 10.1038/sj.emboj.7601592

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  57 in total

1.  The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.

Authors:  J S Steffan; A Kazantsev; O Spasic-Boskovic; M Greenwald; Y Z Zhu; H Gohler; E E Wanker; G P Bates; D E Housman; L M Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Two new proteases in the MHC class I processing pathway.

Authors:  L Stoltze; M Schirle; G Schwarz; C Schröter; M W Thompson; L B Hersh; H Kalbacher; S Stevanovic; H G Rammensee; H Schild
Journal:  Nat Immunol       Date:  2000-11       Impact factor: 25.606

Review 3.  Protein degradation and protection against misfolded or damaged proteins.

Authors:  Alfred L Goldberg
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

4.  A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation.

Authors:  Eric Reits; Joost Neijssen; Carla Herberts; Willemien Benckhuijsen; Lennert Janssen; Jan Wouter Drijfhout; Jacques Neefjes
Journal:  Immunity       Date:  2004-04       Impact factor: 31.745

5.  A genomic screen for modifiers of tauopathy identifies puromycin-sensitive aminopeptidase as an inhibitor of tau-induced neurodegeneration.

Authors:  Stanislav L Karsten; Tzu-Kang Sang; Lauren T Gehman; Shreyasi Chatterjee; Jiankai Liu; George M Lawless; Soma Sengupta; Robert W Berry; Justine Pomakian; Hyun S Oh; Cordula Schulz; Koon-Sea Hui; Martina Wiedau-Pazos; Harry V Vinters; Lester I Binder; Daniel H Geschwind; George R Jackson
Journal:  Neuron       Date:  2006-09-07       Impact factor: 17.173

6.  The Caenorhabditis elegans orthologue of mammalian puromycin-sensitive aminopeptidase has roles in embryogenesis and reproduction.

Authors:  Darren R Brooks; Nigel M Hooper; R Elwyn Isaac
Journal:  J Biol Chem       Date:  2003-08-20       Impact factor: 5.157

7.  Mutation of active site residues of the puromycin-sensitive aminopeptidase: conversion of the enzyme into a catalytically inactive binding protein.

Authors:  Michael W Thompson; Meera Govindaswami; Louis B Hersh
Journal:  Arch Biochem Biophys       Date:  2003-05-15       Impact factor: 4.013

8.  Analysis of conserved residues of the human puromycin-sensitive aminopeptidase.

Authors:  Michael W Thompson; Louis B Hersh
Journal:  Peptides       Date:  2003-09       Impact factor: 3.750

9.  Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins.

Authors:  Prasanna Venkatraman; Ronald Wetzel; Motomasa Tanaka; Nobuyuki Nukina; Alfred L Goldberg
Journal:  Mol Cell       Date:  2004-04-09       Impact factor: 17.970

10.  Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.

Authors:  Wesley Farris; Stefan Mansourian; Yang Chang; Loren Lindsley; Elizabeth A Eckman; Matthew P Frosch; Christopher B Eckman; Rudolph E Tanzi; Dennis J Selkoe; Suzanne Guenette
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-12       Impact factor: 11.205

View more
  39 in total

1.  Dictyostelium puromycin-sensitive aminopeptidase A is a nucleoplasmic nucleomorphin-binding protein that relocates to the cytoplasm during mitosis.

Authors:  Andrew Catalano; Yekaterina Poloz; Danton H O'Day
Journal:  Histochem Cell Biol       Date:  2011-10-25       Impact factor: 4.304

Review 2.  Towards a systems understanding of MHC class I and MHC class II antigen presentation.

Authors:  Jacques Neefjes; Marlieke L M Jongsma; Petra Paul; Oddmund Bakke
Journal:  Nat Rev Immunol       Date:  2011-11-11       Impact factor: 53.106

Review 3.  Recent progress in histochemistry and cell biology.

Authors:  Stefan Hübner; Athina Efthymiadis
Journal:  Histochem Cell Biol       Date:  2012-02-25       Impact factor: 4.304

4.  Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairment.

Authors:  Christa J Maynard; Claudia Böttcher; Zaira Ortega; Ruben Smith; Bogdan I Florea; Miguel Díaz-Hernández; Patrik Brundin; Hermen S Overkleeft; Jia-Yi Li; Jose J Lucas; Nico P Dantuma
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-30       Impact factor: 11.205

Review 5.  The ubiquitin-proteasome pathway in Huntington's disease.

Authors:  Steven Finkbeiner; Siddhartha Mitra
Journal:  ScientificWorldJournal       Date:  2008-04-20

6.  The arginylation branch of the N-end rule pathway positively regulates cellular autophagic flux and clearance of proteotoxic proteins.

Authors:  Yanxialei Jiang; Jeeyoung Lee; Jung Hoon Lee; Joon Won Lee; Ji Hyeon Kim; Won Hoon Choi; Young Dong Yoo; Hyunjoo Cha-Molstad; Bo Yeon Kim; Yong Tae Kwon; Sue Ah Noh; Kwang Pyo Kim; Min Jae Lee
Journal:  Autophagy       Date:  2016-08-25       Impact factor: 16.016

7.  Puromycin-sensitive aminopeptidase: an antiviral prodrug activating enzyme.

Authors:  Ulrika Tehler; Cara H Nelson; Larryn W Peterson; Chester J Provoda; John M Hilfinger; Kyung-Dall Lee; Charles E McKenna; Gordon L Amidon
Journal:  Antiviral Res       Date:  2009-12-05       Impact factor: 5.970

8.  Puromycin-sensitive aminopeptidase protects against aggregation-prone proteins via autophagy.

Authors:  Fiona M Menzies; Raphael Hourez; Sara Imarisio; Marcel Raspe; Oana Sadiq; Dhia Chandraratna; Cahir O'Kane; Kenneth L Rock; Eric Reits; Alfred L Goldberg; David C Rubinsztein
Journal:  Hum Mol Genet       Date:  2010-09-09       Impact factor: 6.150

9.  Aminopeptidases do not directly degrade tau protein.

Authors:  K Martin Chow; Hanjun Guan; Louis B Hersh
Journal:  Mol Neurodegener       Date:  2010-11-05       Impact factor: 14.195

10.  A common motif targets huntingtin and the androgen receptor to the proteasome.

Authors:  Shweta Chandra; Jieya Shao; Jennifer X Li; Mei Li; Frank M Longo; Marc I Diamond
Journal:  J Biol Chem       Date:  2008-06-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.